Prognostic value of FDG PET/CT in head and neck squamous cell carcinomas

被引:14
|
作者
Dequanter, D. [1 ,2 ]
Shahla, M. [2 ]
Aubert, C. [2 ]
Deniz, Y. [2 ]
Lothaire, P. [2 ]
机构
[1] Katholieke Univ Leuven, Lab Expt Radiotherapy, Dept Oncol, Leuven, Belgium
[2] CHU Charleroi, Hop Andre Vesale, Head & Neck Dept, Montignies le Tilleul, Belgium
来源
ONCOTARGETS AND THERAPY | 2015年 / 8卷
关键词
maximum standardized uptake value; PET/CT; head and neck cancer; lymph node metastases; extracapsular spread; POSITRON-EMISSION-TOMOGRAPHY; EXTRACAPSULAR SPREAD; PREDICT;
D O I
10.2147/OTT.S85479
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Introduction: The purpose of this study was to evaluate the use of F-18-fluorodeoxyglucose positron emission tomography/computed tomography (F-18-FDG PET/CT) to identify the presence of cervical lymph nodes metastases and extracapsular spread with histologic correlations in head and neck squamous cell carcinoma. Methods: The medical records of 54 patients who underwent F-18-FDG PET/CT for head and neck squamous cell carcinoma before surgery were reviewed. Receiver operating characteristic (ROC) analysis was performed to differentiate patients with cervical lymph node metastasis from those without lymph node metastasis. The same statistical analysis was done to differentiate cervical lymph nodes with extracapsular spread from those without extracapsular spread. Results: Metastatic disease was diagnosed histologically in 49% (26 of 54) of the patients. Extracapsular spread was present in ten of the 54 patients (19%). When ROC curve analysis and maximum standardized uptake (SUVmax) values were used to detect cervical lymph node metastasis, the area under the ROC curve was 0.96 and the optimal cutoff value for SUVmax was 4.05 based on ROC curve analysis. The sensitivity and specificity of SUVmax for the detection of cervical lymph node metastasis using this cutoff point were 92% and 88%, respectively. When ROC curve analysis and SUVmax values were used in order to detect extracapsular spread, the area under the ROC curve was 0.86, and the optimal cutoff value for SUVmax was 4.15 based on ROC curve analysis. Using this cutoff value, the sensitivity and specificity of SUVmax for the detection of extracapsular spread were 83% and 88%, respectively. Conclusion: In our study, a median F-18-FDG PET/CT SUVmax cutoff value of 4.15 was found to be related with cervical lymph node metastasis and extracapsular spread in patients with head and neck cancer.
引用
收藏
页码:2279 / 2283
页数:5
相关论文
共 50 条
  • [31] Therapeutic and Prognostic Impact Value of FDG PET/CT in Newly Diagnosed Head and Neck Malignancy
    de Juan, R.
    Ruiz, S.
    Sarandeses, P.
    Hernandez, A.
    Ruiz, A.
    Estenoz, J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S515 - S516
  • [32] Clinical value of 18FDG PET/CT in screening for distant metastases in head and neck squamous cell carcinoma
    Deurvorst, S. E.
    Hoekstra, O. S.
    Castelijns, J. A.
    Witte, B. I.
    Leemans, C. R.
    de Bree, R.
    [J]. CLINICAL OTOLARYNGOLOGY, 2018, 43 (03) : 875 - 881
  • [33] Diagnostic Value of FDG-PET/CT for the Identification of Extranodal Extension in Patients With Head and Neck Squamous Cell Carcinoma
    Toya, Ryo
    Saito, Tetsuo
    Matsuyama, Tomohiko
    Kai, Yudai
    Shiraishi, Shinya
    Murakami, Daizo
    Yoshida, Ryoji
    Watakabe, Takahiro
    Sakamoto, Fumi
    Tsuda, Noriko
    Arimura, Hidetaka
    Orita, Yorihisa
    Nakayama, Hideki
    Oya, Natsuo
    [J]. ANTICANCER RESEARCH, 2020, 40 (04) : 2073 - 2077
  • [34] Prognostic value of textural indices extracted from pretherapeutic 18-F FDG-PET/CT in head and neck squamous cell carcinoma
    Guezennec, Catherine
    Robin, Philippe
    Orlhac, Fanny
    Bourhis, David
    Delcroix, Olivier
    Gobel, Yves
    Rousset, Jean
    Schick, Ulrike
    Salaun, Pierre-Yves
    Abgral, Ronan
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (02): : 495 - 502
  • [35] Prognostic Value of Pretreatment 18F-FDG PET/CT Parameters Including Visual Evaluation in Patients With Head and Neck Squamous Cell Carcinoma
    Koyasu, Sho
    Nakamoto, Yuji
    Kikuchi, Masahiro
    Suzuki, Kayo
    Hayashida, Kohei
    Itoh, Kyo
    Togashi, Kaori
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2014, 202 (04) : 851 - 858
  • [36] The Prognostic Value of Pretreatment FDG PET/CT in Patients with Oropharyngeal Squamous Cell Carcinoma
    Jensen, J. Schmidt
    Christensen, J. T.
    Hakansson, K. E.
    Zamani, M.
    Vogelius, I.
    Lofgren, J.
    Fischer, B. M.
    Friborg, J. T.
    Buchwald, C. V.
    Rasmussen, J. H.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 1165 - 1165
  • [37] The Prognostic Role of Claudins in Head and Neck Squamous Cell Carcinomas
    Nelhubel, Gyorgyi A.
    Karoly, Boroka
    Szabo, Balazs
    Lotz, Gabor
    Kiss, Andras
    Tovari, Jozsef
    Kenessey, Istvan
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2014, 20 (01) : 99 - 106
  • [38] Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma
    Cacicedo, J.
    Fernandez, I.
    del Hoyo, O.
    Navarro, A.
    Gomez-Iturriaga, A.
    Ignacio Pijoan, J.
    Martinez-Indart, L.
    Escudero, J.
    Gomez-Suarez, J.
    Ortiz de Zarate, R.
    Fernando Perez, J.
    Bilbao, P.
    Rades, D.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (11): : 1337 - 1349
  • [39] Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma
    J. Cacicedo
    I. Fernandez
    O. del Hoyo
    A. Navarro
    A. Gomez-Iturriaga
    J. Ignacio Pijoan
    L. Martinez-Indart
    J. Escudero
    J. Gomez-Suarez
    R. Ortiz de Zarate
    J. Fernando Perez
    P. Bilbao
    D. Rades
    [J]. Clinical and Translational Oncology, 2017, 19 : 1337 - 1349
  • [40] Nodal staging of head and neck squamous cell carcinomas: Impact of a dedicated PET/CT protocol
    Minon, Anne-Laurence
    Cabay, Jean-Evrard
    Demez, Pierre
    Bernard, Claire
    Moreau, Pierre
    Hustinx, Roland
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53